Cardiology Clinical Trials

Assessment of Proper Physiologic Response with Rate Adaptive Pacing Driven by Minute Ventilation or Accelerometer (APPROPRIATE) Study

• Principal Investigator: Robert Winslow, MD
• Boston Scientific

 

Gauging Responsiveness with A VerifyNow assay- Impact on Thrombosis And Safety (GRAVITAS)

• Principal Investigator: Mark Warshofsky,
• MD Accumetrics/Synteract

 

Protocol NC20971: “A Phase III, Double-Blind, Randomized Placebo-Controlled Study to Evaluate the Effects of Dalcetrapib on Cardiovascular (CV) Risk in Stable CHD Patients, with a Documented Recent Acute Coronary Syndrome (ACS) dal OUTCOMES Trial

• Principal Investigator: Andrew Keller, MD
• Roche/Quintiles

 

A Multi-center, Randomized, Double-Blind, Placebo- Controlled Study to Evaluate the Safety and Efficacy of SCH 530348 in Addition to Standard of Care in Subjects With Acute Coronary Syndrome: Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRA•CER)

• Principal Investigator: Hal Wasserman, MD
• Schering Plough-Merck/Duke Clinical Research

 

Variation in Recovery: Role of Gender on Outcomes of Young Acute Myocardial Infarction Patients (VIRGO)

• Principal Investigator: Susan Mani, MD
• Yale

 

ClosureFAST – Endovascular Radiofrequency Great Saphenous Vein Treatment Using a Catheter with an Integrated Heating Element

• Principal Investigator: Alan Dietzek,MD
• VNUS Medical Technologies

 

Attain Success ClinicalMedtronics

• Principal Investigator: Robert Winslow, MD

 

A Phase 2 Open-Label, Multicenter Study for the Development of One-Day Rest/Stress Cardiac Positron Emission Tomography (PET) Perfusion Imaging Protocols of BMS747158-201(2),”

• Principal Investigator: Teresa Daniele, MD
• Lantheus/BMS